<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dzavakwa NV</submitter><funding>European &amp; Developing Countries Clinical Trials Partnership (EDCTP)</funding><pagination>499</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11264400</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Of the 2 million children living with HIV globally, 90% live in sub-Saharan Africa. Despite antiretroviral therapy, longstanding HIV infection is associated with several chronic complications in children including growth failure, particularly stunting and delayed puberty. Vitamin D deficiency, which is highly prevalent among children living with HIV in sub-Saharan Africa, has further adverse impact on bone health. This trial aims to establish whether supplementation with vitamin D&lt;sub>3&lt;/sub> and calcium carbonate improves musculoskeletal health among peripubertal children living with HIV. This paper is an update to an already existing protocol that was previously published in Trials in 2022 and details changes in the trial outcomes.&lt;h4>Methods/design&lt;/h4>We will conduct</pubmed_abstract><journal>Trials</journal><pubmed_title>Update: Vitamin D&lt;sub>3&lt;/sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.</pubmed_title><pmcid>PMC11264400</pmcid><funding_grant_id>RIA2018CO-2512</funding_grant_id><pubmed_authors>Martineau A</pubmed_authors><pubmed_authors>Mujuru H</pubmed_authors><pubmed_authors>Redzo N</pubmed_authors><pubmed_authors>Ward K</pubmed_authors><pubmed_authors>Mabuda HB</pubmed_authors><pubmed_authors>Gea-Mallorqui E</pubmed_authors><pubmed_authors>Madanhire T</pubmed_authors><pubmed_authors>Sunkutu V</pubmed_authors><pubmed_authors>Hauptmann M</pubmed_authors><pubmed_authors>Weiss HA</pubmed_authors><pubmed_authors>Leschczyk C</pubmed_authors><pubmed_authors>Ferrand RA</pubmed_authors><pubmed_authors>Simms V</pubmed_authors><pubmed_authors>Mudzingwa TS</pubmed_authors><pubmed_authors>VITALITY team</pubmed_authors><pubmed_authors>Mutasa K</pubmed_authors><pubmed_authors>Kelly P</pubmed_authors><pubmed_authors>Schaible UE</pubmed_authors><pubmed_authors>Filteau S</pubmed_authors><pubmed_authors>Rowland-Jones S</pubmed_authors><pubmed_authors>Tembo M</pubmed_authors><pubmed_authors>Manyanga T</pubmed_authors><pubmed_authors>McHugh G</pubmed_authors><pubmed_authors>Kasonka L</pubmed_authors><pubmed_authors>Archary M</pubmed_authors><pubmed_authors>Dzavakwa NV</pubmed_authors><pubmed_authors>Rukuni R</pubmed_authors><pubmed_authors>Kekitiinwa A</pubmed_authors><pubmed_authors>Hameiri-Bowen D</pubmed_authors><pubmed_authors>Kahari C</pubmed_authors><pubmed_authors>Pettifor J</pubmed_authors><pubmed_authors>Kranzer K</pubmed_authors><pubmed_authors>Gregson CL</pubmed_authors><pubmed_authors>Chisenga M</pubmed_authors><pubmed_authors>John-Stewart G</pubmed_authors><pubmed_authors>Rukobo S</pubmed_authors><pubmed_authors>Namukonda C</pubmed_authors><pubmed_authors>Lombard C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Update: Vitamin D&lt;sub>3&lt;/sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.</name><description>&lt;h4>Background&lt;/h4>Of the 2 million children living with HIV globally, 90% live in sub-Saharan Africa. Despite antiretroviral therapy, longstanding HIV infection is associated with several chronic complications in children including growth failure, particularly stunting and delayed puberty. Vitamin D deficiency, which is highly prevalent among children living with HIV in sub-Saharan Africa, has further adverse impact on bone health. This trial aims to establish whether supplementation with vitamin D&lt;sub>3&lt;/sub> and calcium carbonate improves musculoskeletal health among peripubertal children living with HIV. This paper is an update to an already existing protocol that was previously published in Trials in 2022 and details changes in the trial outcomes.&lt;h4>Methods/design&lt;/h4>We will conduct</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-06-01T01:16:05.701Z</modification><creation>2025-06-01T01:16:05.701Z</creation></dates><accession>S-EPMC11264400</accession><cross_references><pubmed>39039558</pubmed><doi>10.1186/s13063-024-08342-z</doi></cross_references></HashMap>